Long-term growth hormone (GH) therapy increases final height in GH-deficient and some non-GH-deficient children

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 20, Iss. 10, 2004-10 ,pp. : 15-17

Adis International

Access to resources Recommend Favorite

Effects of growth hormone deficiency and rhGH replacement therapy on the 6β-hydroxycortisol/free cortisol ratio, a marker of CYP3A activity, in growth hormone-deficient children

By Sinués Blanca   Mayayo Esteban   Fanlo Ana   JR Esteban   Bernal María   Bocos Pilar   Bello Elena   Labarta Jose   Ferrández-Longás Angel  

European Journal of Clinical Pharmacology, Vol. 60, Iss. 8, 2004-10 ,pp. : 559-564

Springer Publishing Company

Access to resources Recommend Favorite

The QoL-AGHDA questionnaire cannot distinguish between the states of severe growth hormone (GH) deficiency and GH excess

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 321, 2001-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

COLIA1 Sp1 polymorphism: towards individualized therapy with injected recombinant hGH in GH-deficient adults?

By Koch Christian A  

Pharmacogenomics, Vol. 9, Iss. 8, 2008-08 ,pp. : 987-988

Future Medicine

Access to resources Recommend Favorite

Association of COLIA1 Sp1 polymorphism with the effect of subcutaneously injected recombinant hGH in GH-deficient adults

By Meyer Silke   Haist Marlitt   Schaefer Stephan   Ivan Diana   Ittner Jochen R   Nawroth Peter P   Plööckinger Ursula   Stalla Güünter K   Tuschy Ulrich   Weber Matthias M   Weise Alexander   Pfüützner Andreas   Habbe Nils   Kann Peter H  

Pharmacogenomics, Vol. 9, Iss. 8, 2008-08 ,pp. : 1017-1026

Future Medicine

Access to resources Recommend Favorite